From 06fb52eebc8c0b7a978467cdf5f9f78e0f3b699a Mon Sep 17 00:00:00 2001 From: borja Date: Thu, 31 Oct 2024 13:00:51 +0100 Subject: [PATCH] Auto saved by Logseq --- journals/2024_10_31.md | 3 ++- 1 file changed, 2 insertions(+), 1 deletion(-) diff --git a/journals/2024_10_31.md b/journals/2024_10_31.md index a9f55dee..afb1ce10 100644 --- a/journals/2024_10_31.md +++ b/journals/2024_10_31.md @@ -18,7 +18,8 @@ - What are these implementation studies that take time and new investment thats the gap being tried to fill. Neither us or Maurice need to engage in how these drugs will be accessed. We're just setting the game for them to discuss. - Stella agrees. Its more showing the path that it takes for new products to be able to be sent out to the masses than the process where is now. - Demonstrating that doing the pivotal trial and submit to regulatory agencies doesn't mean inclusion in programs. - - I got in touch with EDCTP authorities to highlight that PZQ and + - I got in touch with EDCTP authorities to highlight that PZQ and moxi and fdc are all edctp invesments. They are very happy about it. + - Maurice: what i gather is present the clinical findings and highlight what the next steps are. Im' - ### Decisiones - - CANCELED 17:00 - 17:30: Pre-Symposium meeting